Clinical Topics & News
Conference Coverage
Anti-MOG antibodies associated with non-MS, monophasic demyelinating disease in young children
BERLIN – Age and anti-MOG antibody status may help to predict a non-MS diagnosis.
Conference Coverage
Alemtuzumab switch linked to good MS outcomes
Conference Coverage
Higher BMI associated with greater loss of gray matter volume in MS
ATLANTA – Cohort may not be representative of the general MS population.
Conference Coverage
Retinal thinning in aquaporin-4-positive NMOSD may occur without optic neuritis
BERLIN – Finding could be explained by “a disease-related primary retinopathy due to the high density of astrocytic cells in the retina and the...
Conference Coverage
Nf-L levels predictive of brain atrophy, disability in progressive MS
BERLIN – Future brain atrophy and 3-month confirmed disability worsening could be predicted from change in baseline levels of the potential MS...
Conference Coverage
Low spinal cord volume linked to higher MS disability
BERLIN – Spinal cord volume tracked with disability level in patients with a mismatch between disability status and intracerebral lesion load.
Conference Coverage
Relapsing-remitting MS best treated within 6 months of onset
BERLIN – Disease-modifying treatment for relapsing-remitting multiple sclerosis decreased the risk of disability progression at 12 months by 28...
Conference Coverage
Mood disorders worsen multiple sclerosis disability
BERLIN – Men with MS and either depression or bipolar disorder were at especially higher risk of worsening disability.
Conference Coverage
Revamped MS criteria boost pediatric diagnoses
BERLIN – Oligoclonal bands and absence of anti-MoG antibodies are useful clinical markers during a diagnostic work-up.
Conference Coverage
No elevated cancer risk with MS therapies in COMBAT-MS data
BERLIN – No elevations were seen in overall cancer rates, or in breast cancer rates.